Violet Wallerstein On March 6, 23andMe announced that the FDA has approved its first direct-to-consumer test for mutations in the BRCA gene which are linked to breast cancer. This test is following…
Violet Wallerstein On March 6, 23andMe announced that the FDA has approved its first direct-to-consumer test for mutations in the BRCA gene which are linked to breast cancer. This test is following…